SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001827672-23-000048
Filing Date
2023-12-22
Accepted
2023-12-22 17:30:34
Documents
1
Period of Report
2023-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1703284219.html 4  
1 FORM 4 wk-form4_1703284219.xml 4 6974
  Complete submission text file 0001827672-23-000048.txt   8408
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 15440 LAGUNA CANYON ROAD, SUITE 160 IRVINE CA 92618
Business Address
Azamian Bobak R. (Reporting) CIK: 0001827672 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39614 | Film No.: 231510934